No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder worldwide, reaching prevalence up to 90 % in obese patients with type 2 diabetes (T2D), and representing an independent risk factor for cardiovascular mortality. Furthermore, the coexistence of T2D and NAFLD le...

Descripción completa

Detalles Bibliográficos
Autores principales: Barchetta, Ilaria, Del Ben, Maria, Angelico, Francesco, Di Martino, Michele, Fraioli, Antonio, La Torre, Giuseppe, Saulle, Rosella, Perri, Ludovica, Morini, Sergio, Tiberti, Claudio, Bertoccini, Laura, Cimini, Flavia Agata, Panimolle, Francesca, Catalano, Carlo, Baroni, Marco Giorgio, Cavallo, Maria Gisella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926287/
https://www.ncbi.nlm.nih.gov/pubmed/27353492
http://dx.doi.org/10.1186/s12916-016-0638-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926287/
https://www.ncbi.nlm.nih.gov/pubmed/27353492
http://dx.doi.org/10.1186/s12916-016-0638-y

Ejemplares similares